Tirzep 15 Sterile Solution For Injection

✔️ Side Effects

• Headache
• Nausea
• Stomach upset
• Vomiting
• Abdominal pain
• Diarrhoea

✔️ Interaction

Drug-Drug Interactions: Tirzepatide interacts with an antidepressant (bupropion), drugs used to treat glaucoma, antibiotics (cephalexin, ciprofloxacin), anti-acidity drugs (cimetidine), heart condition drugs (digoxin), anti-epileptic drugs (topiramate, lamotrigine), and heart-related chest medicine (ranolazine).

Drug-Food Interactions:  Avoid intake of alcoholic beverages with Tirzepatide.

Drug-Disease Interactions: Inform your doctor if you have any liver/kidney disease, stomach problems, vision problems, pancreatitis, depression, gall bladder problems, or hypoglycaemia.

✔️ Precautions

• Tirzepatide should be avoided if you are allergic to any of its components.
• Before starting treatment, inform your doctor of your medical history and the medications you take, including any herbs or supplements. This can help prevent unwanted effects.
• Tirzepatide is not recommended for use in patients with severe liver/kidney disease, type I diabetes, family history of MTC (medullary thyroid carcinoma) or in patients with multiple endocrine neoplasia syndrome type 2.
• Consult your doctor if you are pregnant or breastfeeding.
• It is not recommended for use in children below 18 years of age.
• Caution should be exercised in conditions like liver/kidney disease, stomach problems, vision problems, pancreatitis, depression, gall bladder problems, malnutrition, and hypoglycemia.

✔️ Dosing Schedule | Tirzepatide

Tirzepatide is administered subcutaneously.

The recommended starting dose is 2.5 mg once weekly, given by subcutaneous injection.

This initial dose is intended only for treatment initiation and is not designed to provide glycemic control.

After 4 weeks, the dose should be increased to 5 mg once weekly.

If further glycemic control is required, the dose may be increased in 2.5 mg increments, with each dose level maintained for at least 4 weeks before escalation.

The maximum recommended dose is 15 mg once weekly.

Missed Dose

If a dose is missed, it should be administered as soon as possible within 4 days (96 hours) of the missed dose.

If more than 4 days have elapsed, the missed dose should be skipped and the next dose administered on the regularly scheduled day.

Patients should then continue with their usual once-weekly dosing schedule.

Change of Dosing Day

The day of weekly administration may be changed if necessary, provided there is a minimum interval of 3 days (72 hours) between doses.

Preparation & Handling

The needle cover of the prefilled syringe contains dry natural rubber (latex derivative) and may cause allergic reactions in susceptible individuals.

Do not freeze Tirzepatide. Discard if the product has been frozen.

Protect prefilled syringes from light.

Inspect visually for particulate matter or discoloration prior to use. Do not use if abnormalities are present.

Handle with care. Do not use the syringe if it has been dropped onto a hard surface.

Do not dilute Tirzepatide and do not mix with other injectable medications.

Administration Instructions

Administer once weekly, at any time of day, with or without food.

Inject subcutaneously into the abdomen, thigh, or upper arm.

Rotate injection sites with each dose to reduce the risk of injection-site reactions.

When used concomitantly with insulin, administer as separate injections and never mix the two products.

Tirzepatide and insulin may be injected into the same body region, but not at adjacent sites.

✔️ Storage Condition